Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer (Q67126541)
Jump to navigation
Jump to search
clinical trial
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Anti-OX40 Antibody (MEDI6469) in Patients With Metastatic Colorectal Cancer |
clinical trial |
Statements
Phase I/Ib Study of Surgical Resection or Radiofrequency Ablation (RFA) of Metastatic Lesions in the Liver in Combination With Monoclonal Antibody to OX40 (MEDI6469) in Patients With Metastatic Colorectal Cancer (English)
0 references
14 March 2016
0 references
September 2020
0 references
4
0 references
18 year
0 references